4//SEC Filing
PASSERI DANIEL R 4
Accession 0001209191-22-022570
CIK 0001645460other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:29 PM ET
Size
10.3 KB
Accession
0001209191-22-022570
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Gift
Common Stock
2022-03-31−10,000→ 131,578 total - Exercise/Conversion
Common Stock
2022-03-31+75,000→ 173,700 total - Tax Payment
Common Stock
2022-03-31$4.88/sh−32,122$156,755→ 141,578 total - Exercise/Conversion
Restricted Stock Units
2022-03-31−75,000→ 0 total→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001190121
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:29 PM ET
- Size
- 10.3 KB